Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   


go back to main search page
Accession:CHEBI:2038 term browser browse the term
Definition:An N-glycosyl-1,3,5-triazine that is 4-amino-1,3,5-triazin-2(1H)-one substituted by a beta-D-ribofuranosyl residue via an N-glycosidic linkage. An antineoplastic agent, it is used in the treatment of myeloid leukaemia.
Synonyms:exact_synonym: 4-amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one
 related_synonym: 4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one;   Azacitidine;   Formula=C8H12N4O5;   InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1;   InChIKey=NMUSYJAQQFHJEW-KVTDHHQDSA-N;   SMILES=Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1;   azacitidina;   azacitidinum
 xref: CAS:320-67-2 "ChemIDplus";   CAS:320-67-2 "KEGG COMPOUND";   DrugBank:DB00928;   Drug_Central:25 "DrugCentral";   HMDB:HMDB0015063;   KEGG:C11262;   KEGG:D03021;   LINCS:LSM-5218
 xref_mesh: MESH:D001374
 xref: PMID:11841042 "Europe PMC";   PMID:15962522 "Europe PMC";   PMID:17611569 "Europe PMC";   PMID:28131982 "Europe PMC";   PMID:28415666 "Europe PMC";   PMID:28486212 "Europe PMC";   PMID:29438107 "Europe PMC";   Patent:KR20140069225;   Patent:US2015038444;   Reaxys:620461 "Reaxys";   Wikipedia:Azacitidine

show annotations for term's descendants       view all columns           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 0
    role 0
      application 0
        pharmaceutical 0
          drug 0
            antineoplastic agent 0
              5-azacytidine 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 0
    subatomic particle 0
      composite particle 0
        hadron 0
          baryon 0
            nucleon 0
              atomic nucleus 0
                atom 0
                  main group element atom 0
                    p-block element atom 0
                      carbon group element atom 0
                        carbon atom 0
                          organic molecular entity 0
                            heteroorganic entity 0
                              organochalcogen compound 0
                                organooxygen compound 0
                                  carbohydrates and carbohydrate derivatives 0
                                    carbohydrate 0
                                      monosaccharide 0
                                        aldose 0
                                          aldopentose 0
                                            ribose 0
                                              D-ribose 0
                                                D-ribofuranose 0
                                                  beta-D-ribose 0
                                                    5-azacytidine 0
paths to the root


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.